RCKT 8-K 2026-10-06

ROCKET PHARMACEUTICALS, INC. (RCKT) 8-K dated 2026-10-06 — accession 0001140361-26-038818.

ROCKET PHARMACEUTICALS, INC. (RCKT) is a biotechnology company listed on US.

ROCKET PHARMACEUTICALS, INC. filed a 8-K on 2026-10-06. Accession 0001140361-26-038818.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RCKT revenue for 2025-12-31 was $0. Net income was -$223.1M. RCKT currently screens at market cap $279.0M.

Not investment advice. The RCKT SEC hub lists recent forms. The stock page is the research view.